Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-08
2008-07-08
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S399000, C549S408000
Reexamination Certificate
active
07396855
ABSTRACT:
A composition for use in making commercial food and skin products comprising S-equol or mixtures, including both a non-racemic mixture and a racemic mixture, of S-equol and R-equol. The composition can be used to make articles of commerce such as food supplements, pharmaceuticals, and medicaments. The compositions are useful in a method of delivering S-equol to a mammal to prevent or treat a disease or associated condition, including hormone-dependent diseases or conditions such as cardiovascular disease, lipid disorder, osteopenia, osteoporosis, liver disease, and acute ovarian estrogen deficiency. The S-equol enantiomer can be produced in a biological synthesis from the metabolism of an isoflavone by an organism.
REFERENCES:
patent: 4390559 (1983-06-01), Zilliken
patent: 4814346 (1989-03-01), Albert et al.
patent: 5141746 (1992-08-01), Fleury et al.
patent: RE34457 (1993-11-01), Okamoto et al.
patent: 5352384 (1994-10-01), Shen
patent: 5424331 (1995-06-01), Shlyankevich
patent: 5498631 (1996-03-01), Gorbach et al.
patent: 5523087 (1996-06-01), Shlyankevich
patent: 5726034 (1998-03-01), Bryan et al.
patent: 5733926 (1998-03-01), Gorbach
patent: 5804234 (1998-09-01), Suh et al.
patent: 5830887 (1998-11-01), Kelly
patent: 5849798 (1998-12-01), Charpentier et al.
patent: 5855892 (1999-01-01), Potter et al.
patent: 5942539 (1999-08-01), Hughes, Jr. et al.
patent: 5952374 (1999-09-01), Clarkson, Jr. et al.
patent: 5958946 (1999-09-01), Styczynski et al.
patent: 5990291 (1999-11-01), Waggle et al.
patent: 6004558 (1999-12-01), Thurn et al.
patent: 6020471 (2000-02-01), Johns et al.
patent: 6054636 (2000-04-01), Fader
patent: 6060070 (2000-05-01), Gorbach
patent: 6083526 (2000-07-01), Gorbach
patent: 6146668 (2000-11-01), Kelly et al.
patent: 6159959 (2000-12-01), Miller
patent: 6194450 (2001-02-01), Charpentier et al.
patent: 6242594 (2001-06-01), Kelly
patent: 6258856 (2001-07-01), Chamberlain et al.
patent: 6326366 (2001-12-01), Potter et al.
patent: 6340703 (2002-01-01), Kelly
patent: 6375994 (2002-04-01), Paul et al.
patent: 6455032 (2002-09-01), Kelly et al.
patent: 6497906 (2002-12-01), Kelly
patent: 6509043 (2003-01-01), Høie
patent: 6518301 (2003-02-01), Barlaam et al.
patent: 6544566 (2003-04-01), Waggle et al.
patent: 6562380 (2003-05-01), Kelly
patent: 6565864 (2003-05-01), Pillai et al.
patent: 6599536 (2003-07-01), Kelly et al.
patent: 6628543 (2003-09-01), Stobbs
patent: 6642212 (2003-11-01), Kelly
patent: 6649648 (2003-11-01), Kelly et al.
patent: 6716424 (2004-04-01), Shimizu et al.
patent: 7025998 (2006-04-01), Senin et al.
patent: 2002/0001565 (2002-01-01), Shapiro
patent: 2002/0019377 (2002-02-01), Jenkins et al.
patent: 2002/0035074 (2002-03-01), Kelly
patent: 2002/0160064 (2002-10-01), Zulli et al.
patent: 2002/0198248 (2002-12-01), Kelly et al.
patent: 2003/0018060 (2003-01-01), Kelly et al.
patent: 2003/0027772 (2003-02-01), Breton
patent: 2003/0059384 (2003-03-01), Kelly et al.
patent: 2003/0078214 (2003-04-01), Kelly
patent: 2003/0219499 (2003-11-01), Kelly et al.
patent: 20006896 (2000-05-01), None
patent: H02-124883 (1990-05-01), None
patent: WO 93/23069 (1993-11-01), None
patent: WO 94/23716 (1994-10-01), None
patent: WO 96/10341 (1996-04-01), None
patent: WO 97/06273 (1997-02-01), None
patent: WO 98/21946 (1998-05-01), None
patent: WO 98/26784 (1998-06-01), None
patent: WO 98/48790 (1998-11-01), None
patent: WO 99/49851 (1999-10-01), None
patent: WO 99/61028 (1999-12-01), None
patent: WO 00/13661 (2000-03-01), None
patent: WO 00/30663 (2000-06-01), None
patent: WO 00/41491 (2000-07-01), None
patent: WO 00/49009 (2000-08-01), None
patent: WO 00/62765 (2000-10-01), None
patent: WO 00/62774 (2000-10-01), None
patent: WO 02/03976 (2002-01-01), None
patent: WO 02/03977 (2002-01-01), None
patent: WO 02/03992 (2002-01-01), None
patent: WO 02/11675 (2002-02-01), None
patent: WO 02/053108 (2002-07-01), None
patent: WO 02/062367 (2002-08-01), None
patent: WO 02/087517 (2002-11-01), None
patent: WO 02/089757 (2002-11-01), None
patent: WO 04/022023 (2004-03-01), None
patent: WO 04/026274 (2004-04-01), None
patent: WO 04/039327 (2004-05-01), None
US 6,448,237, 09/2002, Kelly (withdrawn)
Jaonnou et al., J. Steroid. Biochem. Molec. Biol., 54, 167-184.
Lamberton et al, Aust. J. Chem., 1978, 31, 455-7, especially p. 457, Experimental (b),last sentence.
Merck Index, 1996, 12th Edition, p. 3677.
Luk et al., J. Natural Product,s 46(6), 852-861, especially p. 853.
Setchell et al., Am. J. Clin. Nutr., 2002, 76, 447-53, especially p. 447, col. 2, approximately lines 20-21.
Shelnutt et al., Am. J. Clin. Nutr., 2002, 76, 588-94, especially p. 588, col. 2, approximately lines 15 and 16.
LC Laboratories and US Biological product list.
Setchell, Kenneth D. R. et al., Bioavailability of Pure isoflavones In Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements, American Society for Nutritional Sciences, 2001, pp. 1362S-1375S.
Brown, Nadine M. et al., Animal Models Impacted by Phytoestrogens in Commercial Chow: Implications for Pathways Influenced by Hormones, Laboratory Investigation, May 2001, vol. 81, No. 5, pp. 735-747.
Setchell, Kenneth D. R. et al., Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability, Am J Clin Nutri 2002, 76, pp. 447-453.
Wähälä, Kristiina et al., Synthesis of the [2H]—Labelled Urinary Lignans, Enterolactone and Enterodiol, and the Phytoestrogen Daidzein and its Metabolites Equol andO-Demethyl-angolensin, J. Chem. Soc. Perkin Trans. I. 1986. pp. 95-98.
Kohli, J.C. et al., Specific separation of equol from estrogens by thin-layer chromatography, Journal of Chromatography, 129 (1976), pp. 473-474, Elsevier Scientific Publ. Co., Amsterdam.
Lamberton, John A. et al., Catalytic Hydrogenation of Isoflavones. The Preparation of (±)-Equol and Related Isoflavans. Aust. J. Chem., 1978, 31, pp. 455-457.
Atsutane, Ohta et al., A combination of Dietary Fructooligosaccharides and Isoflavone Conjugates Increases Femoral Bone Mineral Density and equol Production in Ovariectomized Mice, American Society for Nutritional Sciences. 2002. pp. 2048-2054.
Setchell, KDR et al., Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. The American journal of Clinical Nutrition 40. Sep. 1984, pp. 569-578.
Alvira, E. et al., Molecular modeling study for chiral separation of equol enantiomers by β-cyclodextrin, Chemical Physics 240 (1999), pp. 101-108, Elsevier Science B.V.
Anderson, Edith L. et al., The Identification of Equol as 7-Hydroxy-3-(4′-Hydroxyphenyl) Chroman, and the Synthesis of Racemic Equol Methyl Ether, J. Biol. Chem. 127: 649-56 (1939).
Chiralcel® OD. Instruction Sheet, Daicel Chemical Industries, Ltd., Japan, May 1, 1995.
Chiralcel® OD, Instruction Sheet, Daicel Chemical Industries, Ltd., Exton, PA, Dec. 6, 1994.
Setchell, K.D.R. et al., Dietary Phytoestrogens and Their Effect on Bone: Evidence from In Vitro and In Vivo, Human Observational, and Dietary Intervention Studies, Am J Clin Nutr, 2003; 78 (suppl): 593S-609S.
Sigma-Aldrich webpage. Equol, Product No. 45405, Jul. 10, 2003.
Sigma-Aldrich webpage, (±)-Equol, Product No. 45405, Oct. 23, 2003.
Bowey, E. et al., Metabolism of Isoflavones and Lignans by the Gut Microflora: a Study in Germ-Free and Human Flora Associated Rats, Food Chem Toxicol., May 2003; 41 (5):631-6, Abstract only.
Rafii F. et al., Variations in Metabolism of the Soy Isoflavonoid Daidzen by Human Intestinal Microfloras from Different Individuals, Arch Microbiol., Jul. 2003; 180(1): 11-6, Epub May 29, 2003, Abstract only.
Widyarini S. et al., Isoflavonoid Compounds from Red Clover (Trifolium Pratense) Protect from Inflammation and Immune Suppression Induced by UV Radiation, Photochem Photobiol, Sep. 2001; 74(3): 465-70, Abstract only.
Rowland I.R. et al., Interindividual Variation in Metabolism of Soy Isoflavones and Lignans: Influence of Habitual Diet on Equol Production by the Gut Microflora, Nutr Cancer, 2000; 36(1): 27-32, Abstract only.
Kaziro R. et
Cole Sidney John
Setchell Kenneth David Reginald
Australian Health & Nutrition Assoc. Ltd.
Children's Hospital Medical Center
Chung Susannah
RothWell, Figg, Ernst & Manbeck P.C.
Shiao Rei-tsang
LandOfFree
Compositions and products containing S-equol, and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and products containing S-equol, and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and products containing S-equol, and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2742686